Products

The Company's initial product portfolio includes:

• Purification products for high-value antibodies and biopharmaceutical proteins.
• Research kits for sensitive and specific detection of key genetic regulatory molecules (microRNAs) that appear to be involved in a wide array of diseases (e.g. cancer, diabetes and neurological disorders).
• Infectious disease detection products for the rapid and accurate identification of disease-causing bacteria (including MRSA).
• Stem cell research reagents for quantitative analysis of cell structure, function and differentiation state.